ReviewCancer immunology, immunotherapy : CII2009

Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged.

Yu Cheng Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.